Study P205
Ended Awarded Last action
- Contract number
- HHSN27200017
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $964,412
Award facts
- Opportunity
-
- NIAIDDAIDSNIHAI2012138 Solicitation number
- Contract value 100% obligated
- $964,411.81 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$85,103 | |
| Funding Only Action | $2,799 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $331,449 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $715,267 |
About this award
This is a federal contract award to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The contract, valued at $964,411.81, is for the Simian Vaccine Evaluation Units program, which supports the development of vaccines and countermeasures for infectious diseases. The contract does not have a set-aside designation. ABL is a contract research and manufacturing organization with expertise in biologics development, including vaccines, therapeutics, and diagnostics. The company has been awarded numerous federal contracts and grants, particularly from NIH and HHS, to advance the development of medical countermeasures for various infectious diseases and other health conditions.
Quick answers
Who was awarded contract HHSN27200017?
HHSN27200017 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 29, 2017.
How much is contract HHSN27200017 worth?
The government has obligated $964,412 on HHSN27200017.
Is contract HHSN27200017 an order under another contract?
Yes. HHSN27200017 is a delivery order under HHSN272201300002I, an indefinite delivery contract, on Simian Vaccine Evaluation Units 2013-2020.
Was contract HHSN27200017 competed?
The extent of competition for HHSN27200017 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award